Abstract

With the development of nonlinear optics and new imaging methods, near-infrared (NIR) light can excite contrast agents to probe biological specimens both functionally and structurally with a deeper imaging depth and a higher spatial resolution than linear optical approaches. There is considerable and growing interest in how biological specimens respond to NIR light. Moreover, the visible absorption band of most functional nanomaterials becomes NIR-excitable through multiphoton processes, thus allowing multifunctional imaging and combined therapy with noble metal and magnetic nanoparticles both in vitro and in vivo. A groundbreaking example is the use of different laser techniques to excite single-type NIR-absorbing/emitting nanomaterials to produce multiphoton emission by femtosecond lasers using either a remote control system for photodynamic therapy or photo-induced chemical bond dissociation. These techniques provided superior anatomical resolution and detection sensitivity for in vivo tumor-targeted imaging than those offered by conventional methods. Here we summarize the most recent progress in the development of smart NIR-absorbing/emitting nanomaterials for in vivo bioapplications. Nanomaterials that absorb or emit near-infrared light are increasingly being used to probe the structures and functions of biosystems. In particular, they are valuable for in vivo monitoring of drug nanocarriers, which offer many advantages over conventional drug-delivery methods. Joao Conde of Massachusetts Institute of Technology in the USA and co-workers give a timely review of recent progress in this area. They consider the various types of near-infrared absorbing and emitting nanomaterials. The scientists assess nine kinds of nanoparticles that are useful for multiphoton microscopy. They then overview toxicity studies of these materials. Finally, the researchers provide a roadmap for future research by listing ten properties that ideal near-infrared bioprobes would possess. Specifically, they note that ideal bioprobes should be biocompatible, versatile and multifunctional. A huge interest shows that optical contrast agents to probe biological specimen both functionally and structurally with deeper action depth and better spatial resolution is closely related with the development of near-infrared (NIR) light excitation and nonlinear optics and new imaging methods. This review will go beyond the state-of-the-art by revisiting the up-to-date progress in developing smart NIR-to-NIR and upconverted nanomaterials for in vivo bioapplications. The latest advances in the development of novel NIR-to-NIR linear and nonlinear optical nanomaterials and their potential applications in cancer targeting, diagnosis and therapeutics and deep-tissue imaging are described.

Highlights

  • With functionalized loading matrices, nanometer-sized drug carriers can cross physiological barriers, effectively deliver therapeutics to pathological foci and release their cargo ‘on-demand’ by photo-/ chemo-/thermo-triggering.[1]

  • One of the most common strategies used to maintain stability when circulating in blood plasma is to engraft a layer of polymer, such as poly(ethylene glycol) (PEG), onto the surface of the particles to build up steric repulsion against opsonin proteins,[2] PEG-specific antibodies can subsequently form.[3]

  • CONCLUDING REMARKS: THE FUTURE OF NIR NANOMATERIALS By replacing the single-photon excitation of dye molecules, ultrafast NIR excitation-to-multiphoton and NIR CW laser-UC nanomaterials have mostly expanded the long-standing limitations of optical microscopy that are specific to transition properties and contrast mechanisms

Read more

Summary

INTRODUCTION

Nanometer-sized drug carriers can cross physiological barriers, effectively deliver therapeutics to pathological foci and release their cargo ‘on-demand’ by photo-/ chemo-/thermo-triggering.[1]. To avoid fast renal clearance from the circulation and non-specific permeation through fenestrated sinusoids of the liver/lymphoid/bone marrow/spleen, the carrier size must be 420 nm.[4,5] 100–200 nm-sized nanoparticles (NPs) may pass through the pores of vessels in the tumor microenvironment,[6] considering the tissue penetration and treatment outcome, particles o50 nm would be a better choice.[7] With these design considerations, an ideal drug carrier needs to possess the NIR-active properties, loading matrices, surface modifications and targeting functionalization, all within a size range of 20–50 nm. It is wise to shift both the excitation and emission wavelengths into the NIR region, which enables excitation deeper in the tissue and improves the optical/luminescence contrast Such novel NIR labels require the nanomaterials to be engineered to efficiently absorb and emit in this spectral range.

NPG Asia Materials
Iron oxide NPs
Findings
TOXICITY OF NIR NPS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call